Translate this page into:
Atypical Smith-McCort dysplasia: A case report of skeletal dysplasia with cardiac anomaly
*Corresponding author: Md Ejaz Alam, Department of Endocrinology, Government Medical College, Srinagar, Jammu and Kashmir, India. drmdejazalam@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Alam M, Naga BS, Baba MS, Bhat MH. Atypical Smith-McCort dysplasia: A case report of skeletal dysplasia with cardiac anomaly. Karnataka Paediatr J. doi: 10.25259/KPJ_72_2025
Abstract
Smith-McCort dysplasia (SMC) is a rare autosomal recessive disease characterised by short-trunk dwarfism, skeletal dysplasia, and platyspondyly. It is closely related to Dyggve–Melchior–Clausen syndrome, but patients with SMC have normal mental functions. Both disorders are caused by mutations in the Dymeclin gene (DYM). We report the case of an 8-year-old girl presenting with disproportionate short stature, rhizomelic limb shortening, pectus carinatum, Harrison sulcus, and metaphyseal dysplastic changes in the knee, hip and shoulder joints. Genetic analysis identified a mutation in the DYM gene: Homozygous splice site variant (c.1126-2A>G). Notably, echocardiography revealed a small secundum atrial septal defect, a finding rarely associated with SMC.
Keywords
Dymeclin
Short stature
Skeletal dysplasia
Smith-McCort dysplasia
INTRODUCTION
Smith-McCort dysplasia (SMC) and Dyggve–Melchior–Clausen dysplasia (DMCD) are rare autosomal recessive disorders within the Spondyloepimetaphyseal dysplasia (SEMD) spectrum.[1] SMC is considered a less severe variant of DMCD. The clinical features include short-trunk dwarfism, SEMD and platyspondyly with distinctive lacy iliac crests. However, SMC lacks the intellectual disability typically seen in DMCD.[2,3] SMC is caused by a mutation in the Dymeclin (DYM) gene, located at chromosome 18q12-q21.1 and produces a Golgi protein expressed in bone, cartilage, and brain, whose function is unknown as of now.[4,5] We report the case of an 8-year-old girl who presented with disproportionate short stature with clinical features consistent with SMC and a mutation in the DYM gene.
CASE REPORT
An 8-year-old girl, first in birth order, born of 3rd-degree consanguinity (both Indian parents), was brought with concern of short stature. She was born full term by lower segment caesarean section for breech presentation with an approximate birth weight of 2.5 kg. The parents denied a history of neonatal hypoglycaemia, prolonged physiological jaundice, or respiratory distress. She had delayed motor milestones, while her school performance was good. She had no history of chronic diarrhoea, recurrent respiratory tract infections, breathlessness, or joint pains. Her parents also noticed progressive deformity in her legs. No other family members had similar complaints. On examination, her weight was 12.5 kg (−3.93 SDS), height was 96.6 cm (−5.2 SDS), BMI 13.56 kg/m2, upper segment/lower segment ratio was 1.18, and head circumference was 48 cm. She had an arm span of 90 cm with rhizomelic shortening of the upper limbs, pectus carinatum, Harrison sulcus, and bowing of the legs [Figure 1]. Her higher mental functions were normal with no signs of neurological, hearing, or vision impairment. The spine was normal on examination. Her baseline investigations, including a haemogram, kidney function, and liver function tests, were routine. Her 25-hydroxy Vitamin D was low, and thyroid function tests were normal [Table 1]. A skeletal survey revealed lacy iliac crests, with wrist, knee, hip joints dysplasia and pubic symphysis defect [Figure 2]. Echocardiography showed a small secundum atrial septal defect with a left-to-right shunt, while abdominal ultrasound was unremarkable, showing no evidence of hepatosplenomegaly or renal abnormality.

- Photograph of patients depicting rhizomelic shortening of upper limb, pectus carinatum, harrison sulcus.
| Parameter | Value | Normal range |
|---|---|---|
| Haemogloblin (g/dL) | 14.2 | 12–16 |
| Total leucocyte count (103 μ/L) | 10.5 | 4–12 |
| Platelet count (103 μ/L) | 310 | 130–440 |
| Urea (mg/dL) | 26 | 10–50 |
| Creatinine (mg/dL) | 0.36 | 0.5–1.5 |
| Bilirubin (mg/dL) | 0.8 | 0.2–1.2 |
| Alanine aminotransferase (U/L) | 28 | 0–42 |
| Aspartate aminotransferase (U/L) | 10 | 5-38 |
| Alkaline phosphatase (U/L) | 110 | 40–150 |
| Total protein (mg/dL) | 6.9 | 6.4–8.3 |
| Albumin (mg/dL) | 4.3 | 3.0–5.0 |
| Calcium (mg/dL) | 9.4 | 8.4–10.5 |
| Phosphorous (mg/dL) | 4.5 | 2.3–4.7 |
| 25-hydroxy Vitamin D (ng/mL) | 11.8 | 30–60 |
| Intact parathyroid (pg/mL) hormone | 46.5 | 10–65 |
| Total tetraiodothyronine (μg/dL) | 8.9 | 4.87–11.72 |
| Total triiodothyronine (ng/mL) | 1.4 | 0.60–1.60 |
| Thyroid-stimulating hormone mIU/L | 3.5 | 0.35–4.9 |
| Sodium (mmol/L) | 138.0 | 136–150 |
| Potassium (mmol/L) | 4.0 | 3.5–5.1 |

- Radiographic skeletal abnormalities. (a) Lucent metaphyseal band with metaphyseal widening, splaying, and cupping (arrowheads). (b) Decreased bone density with medullary widening (arrowhead). (c) Lacy outline of the iliac crests (arrows), dysplasia of the acetabulum and femoral heads (arrowheads), and pubic symphysis defect (arrowheads).
Genetic analysis through whole-exome sequencing identified a homozygous 3’ splice site variant in intron 10 of the DYM gene (c.1126-2A>G), which is classified as likely pathogenic. This variant is associated with DMCD and SMC, both autosomal recessive conditions. Based on the clinical, radiological, and genetic findings, a diagnosis of SMC was made.
DISCUSSION
SMC was first described by Smith and McCort in 1958 as an allelic variant of DMCD. Both disorders are uncommon, autosomal recessive disorders caused by mutations in the DYM gene, localised to the 18q12-21.1 chromosomal region, resulting in shared skeletal dysmorphism.[3] Some patients have also been identified to have mutations in the RAB33B gene. Despite identical skeletal abnormalities, patients with SMC have normal intellectual functions. The distinctive radiographic features include generalised platyspondyly with double-humped end-plates [Figure 3] and the lace-like appearance of iliac crests.[2,6] Almost all patients have short stature, short trunks, and rhizomelia.

- Lateral X-ray of spine showing characteristic generalised platyspondyly with double-humped end-plates (arrowhead).
The mutations in DMCD result in premature truncations of the protein, while the mutations in the DYM gene in SMC are missense and heterogeneous, resulting in milder loss of protein functions.[7-11] In this case, a homozygous 3’ splice site variant in intron 10 of the DYM gene (chr18: g.49272305T>C) that affects the invariant AG acceptor splice site upstream of exon 11 (c.1126-2A>G; ENST00000675505.1) was detected. The observed variant has been reported as likely pathogenic in the ClinVar database. The variant has not been reported in the 1000 genomes, gnomAD (v3.1), gnomAD (v2.1) and top med databases. This variant was also found to be damaging by pathogenicity prediction tools, MutationTaster2.
The clinical features observed in this patient such as short trunk, barrel chest, rhizomelic upper limbs, pectus carinatum and genu varum or valgum, with normal intelligence, are typical clinical characteristics of SMC.[6-8] The presence of a small secundum ASD (LDu shunt) on ECHO is not commonly associated with SMC. This finding may be an incidental anomaly or could represent a previously unreported association with DYM gene mutations.
CONCLUSION
SMD is closely related to DMCD with characteristic clinical and radiological findings, However, this is the first case reporting, the presence of ostium secundum atrial septal defect in SMD.
Ethical approval:
Institutional Review Board approval is not required.
Declaration of patient consent:
The authors certify that they have obtained all appropriate parental consent forms. In the form, the parents have given consent for the patient’s images and other clinical information to be reported in the journal. The parents understand that the patient’s name and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Conflicts of interest:
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation:
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript, and no images were manipulated using AI.
Financial support and sponsorship: Nil.
References
- International classification of osteochondrodysplasias. International Working Group on Constitutional Diseases of Bone. Am J Med Genet. 1992;44:223-9.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical, radiological and molecular studies in 24 individuals with Dyggve-Melchior-Clausen dysplasia and Smith-McCort dysplasia from India. J Med Genet. 2023;60:204-11.
- [CrossRef] [Google Scholar]
- Evidence that Smith-McCort dysplasia and Dyggve-Melchior-Clausen dysplasia are allelic disorders that result from mutations in a gene on chromosome 18q12. Am J Hum Genet. 2002;71:947-51.
- [CrossRef] [PubMed] [Google Scholar]
- Dyggve-Melchior-Clausen syndrome and Smith-McCort dysplasia: Clinical and molecular findings in three families supporting genetic heterogeneity in Smith-McCort dysplasia. Am J Med Genet A. 2006;140:421-6.
- [CrossRef] [PubMed] [Google Scholar]
- Dyggve-Melchior-Clausen syndrome without mental retardation (Smith-McCort dysplasia): Morphological findings in the growth plate of the iliac crest. Am J Med Genet. 1997;72:11-7.
- [CrossRef] [Google Scholar]
- Dyggve-Melchior-Clausen syndrome without mental retardation (Smith-McCort dysplasia) Diagn Interv Radiol. 2005;11:163-5.
- [Google Scholar]
- A novel frameshift mutation and infrequent clinical findings in two cases with DyggveMelchior-Clausen syndrome. Clin Dysmorphol. 2014;23:1-7.
- [CrossRef] [PubMed] [Google Scholar]
- Portuguese case of Smith-McCort syndrome caused by a new mutation in the dymeclin (FLJ20071) gene. Clin Dysmorphol. 2009;18:41-4.
- [CrossRef] [PubMed] [Google Scholar]
- A novel RAB33B mutation in Smith-McCort dysplasia. Hum Mutat. 2013;34:283-6.
- [CrossRef] [PubMed] [Google Scholar]
- Further defining the molecular spectrum and long-term follow-up of 17 patients with DyggveMelchior-Clausen and Smith-McCort dysplasia type 2. Am J Med Genet A. 2024;194:e63785.
- [CrossRef] [PubMed] [Google Scholar]
- Dyggve-Melchior-Clausen syndrome: Clinical, genetic, and radiological study of 15 Egyptian patients from nine unrelated families. J Child Orthop. 2009;3:451-8.
- [CrossRef] [PubMed] [Google Scholar]
